1. Home
  2. TLSA vs CURR Comparison

TLSA vs CURR Comparison

Compare TLSA & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • CURR
  • Stock Information
  • Founded
  • TLSA 2013
  • CURR 2013
  • Country
  • TLSA United Kingdom
  • CURR Singapore
  • Employees
  • TLSA N/A
  • CURR N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • CURR Business Services
  • Sector
  • TLSA Health Care
  • CURR Consumer Discretionary
  • Exchange
  • TLSA Nasdaq
  • CURR Nasdaq
  • Market Cap
  • TLSA 187.0M
  • CURR 151.4M
  • IPO Year
  • TLSA 2000
  • CURR N/A
  • Fundamental
  • Price
  • TLSA $1.66
  • CURR $1.67
  • Analyst Decision
  • TLSA
  • CURR Strong Buy
  • Analyst Count
  • TLSA 0
  • CURR 1
  • Target Price
  • TLSA N/A
  • CURR $3.50
  • AVG Volume (30 Days)
  • TLSA 369.4K
  • CURR 256.8K
  • Earning Date
  • TLSA 05-06-2025
  • CURR 08-04-2025
  • Dividend Yield
  • TLSA N/A
  • CURR N/A
  • EPS Growth
  • TLSA N/A
  • CURR N/A
  • EPS
  • TLSA N/A
  • CURR N/A
  • Revenue
  • TLSA N/A
  • CURR $41,092,419.00
  • Revenue This Year
  • TLSA N/A
  • CURR N/A
  • Revenue Next Year
  • TLSA N/A
  • CURR $14.56
  • P/E Ratio
  • TLSA N/A
  • CURR N/A
  • Revenue Growth
  • TLSA N/A
  • CURR N/A
  • 52 Week Low
  • TLSA $0.63
  • CURR $0.33
  • 52 Week High
  • TLSA $2.60
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 40.76
  • CURR 49.04
  • Support Level
  • TLSA $1.73
  • CURR $1.60
  • Resistance Level
  • TLSA $1.90
  • CURR $1.80
  • Average True Range (ATR)
  • TLSA 0.15
  • CURR 0.14
  • MACD
  • TLSA -0.05
  • CURR -0.02
  • Stochastic Oscillator
  • TLSA 24.19
  • CURR 32.97

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: